COMMUNIQUÉS West-GlobeNewswire

Imaging3 Announces the Appointment of Joe Biehl as CFO
08/03/2018
BURBANK, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- Burbank, March 8, 2018: Imaging3, Inc. (OTCQB:IGNG), a development stage company targeting disruptive technologies in the medical imaging industry is pleased to [...]
Bavarian Nordic Announces Phase 2 Trial Investigating Combination of Its Immunotherapy CV301 and Nivolumab in Microsatellite Stable Colorectal Cancer
08/03/2018
Bavarian Nordic and Bristol-Myers Squibb agree to supply clinical material for the trial Investigator-led study represents the fourth clinical combination of CV301 with a checkpoint inhibitor COPENHAGEN, Denmark, March [...]
Galectin Therapeutics to Present at 2nd Annual H.C. Wainwright NASH Investor Conference
08/03/2018
NORCROSS, Ga., March 08, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT ), the leading developer of therapeutics that target galectin proteins, today announced that Dr. Harold Shlevin, the Company’s [...]
Agritek Holdings, Inc. Announces Purchase Order For First 10,000 Vaporizer Cartridges Under Company's MD VapeLine To California Licensed Facility
08/03/2018
LOS ANGELES, CA, March 08, 2018 (GLOBE NEWSWIRE) -- Agritek Holdings, Inc. (OTCQB:AGTK) ("the Company") ( www.AgritekHoldings.com ) a fully integrated, active cannabis real estate investor and branding consultant in the [...]
EyeGate Pharma Submits Investigational Device Exemption Amendment for Second Pilot Study of Ocular Bandage Gel
08/03/2018
WALTHAM, Mass., March 08, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG ) (“EyeGate” or the “Company”), a clinical-stage, specialty pharmaceutical company with two proprietary platform [...]
MJ Biotech, Inc Financial Corporate Update
08/03/2018
CHEYENNE, Wyo., March 08, 2018 (GLOBE NEWSWIRE) -- MJ Biotech, Inc. (FKA Michael James Enterprises, Inc.) (OTC:MJTV) Zen’s Tea House, sales results for February 2018 were just over $138,000; combining that with the [...]
Mexico’s COFEPRIS (Mexico’s equivalent of the FDA) approves Biomerica colorectal screening test to help identify the early warning signs of colorectal cancer
08/03/2018
IRVINE, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA ) announced the Mexico’s COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios - Mexico’s equivalent of the U.S. Food [...]
Organovo to Present at 30th Annual ROTH Conference
08/03/2018
SAN DIEGO, March 08, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO ) (“Organovo”) today announced that Chief Financial Officer Craig Kussman is scheduled to speak at the 30 th Annual ROTH Conference in [...]
Catalyst Pharmaceuticals to Hold Fourth Quarter and Year-End Financial Results Conference Call and Webcast on Thursday, March 15th, 2018
08/03/2018
CORAL GABLES, Fla., March 08, 2018 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq: CPRX ), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare [...]
Iovance Biotherapeutics to Host Conference Call to Discuss Fourth Quarter and Year-End 2017 Financial Results and Provide a Corporate Update on Monday, March 12, 2018
08/03/2018
SAN CARLOS, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA ), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) [...]
Intra-Cellular Therapies to Present at the Cowen and Company 38th Annual Health Care Conference
08/03/2018
NEW YORK, March 08, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI ), a biopharmaceutical company focused on the development of therapeutics for central nervous system ("CNS") disorders, today [...]
Cidara Therapeutics to Present Rezafungin Data at the European Society for Blood and Marrow Transplantation 2018 Meeting
08/03/2018
SAN DIEGO, March 08, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX ), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that two rezafungin abstracts [...]
Foamix Pharmaceuticals to Present at the Barclays Global Healthcare Conference 2018
08/03/2018
REHOVOT, Israel, and BRIDGEWATER, N.J., March 08, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX ), (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing and [...]
Albireo to Report Fourth Quarter and Year-End 2017 Financial Results and Host Conference Call and Webcast on March 15, 2018
08/03/2018
BOSTON, March 08, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO ), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that its fourth quarter and [...]
Tyme Technologies Announces Closing of Public Offering of Common Stock
08/03/2018
NEW YORK, March 08, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME ) (“Tyme” or the “Company”) announced today that, on March 6, 2018, it closed its underwritten public offering of 9,000,000 shares of [...]
Ogilvy CommonHealth Worldwide’s WLPN sponsors six rising stars to join the 2018 HBA Mentoring Program
08/03/2018
PARSIPPANY, N.J., March 08, 2018 (GLOBE NEWSWIRE) -- Ogilvy CommonHealth Worldwide ( www.ogilvychww.com ), a WPP Health & Wellness company (NYSE: WPP ) ( www.wpp.com ), today announced that the network’s Nina [...]
UroGen Pharma to Report Fourth Quarter and Full Year 2017 Financial Results on Thursday, March 15, 2018
08/03/2018
Conference Call and Webcast Scheduled for 8:30 AM ET RA’ANANA, Israel and NEW YORK, March 08, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (NASDAQ: URGN ) today announced that it will report fourth quarter and full year [...]
Gemphire to Present at Two Investor Conferences
08/03/2018
LIVONIA, Mich., March 08, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP ), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders [...]
Dermira to Present at Cowen & Company 38th Annual Healthcare Conference
08/03/2018
MENLO PARK, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM ), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new [...]

Pages